13G Filing: Eagle Asset Management Inc Updates Akebia Therapeutics, Inc. (AKBA) Position
A new 13G filing has been submitted to the SEC by Eagle Asset Management, in relation to the investor's position in Akebia Therapeutics, Inc. (NASDAQ:AKBA), which stands at 12.91% of its common stock.